title: Perspectives on chemoprevention agent selection and short-term clinical prevention trials.
authors.affiliation: Chemoprevention Branch, National Cancer Institute (NCI), National Institutes of Health, Bethesda, Maryland 20892, USA.
authors.forename: G J
authors.initials: GJ
authors.lastname: Kelloff
authors.forename: E T
authors.initials: ET
authors.lastname: Hawk
authors.forename: J A
authors.initials: JA
authors.lastname: Crowell
authors.forename: C W
authors.initials: CW
authors.lastname: Boone
authors.forename: V E
authors.initials: VE
authors.lastname: Steele
authors.forename: R A
authors.initials: RA
authors.lastname: Lubet
authors.forename: C C
authors.initials: CC
authors.lastname: Sigman
mesh_terms: D016588:Anticarcinogenic Agents / Q000627:therapeutic use*; D001940:Breast; D017322:Clinical Trials, Phase II as Topic; D003106:Colon; D005260:Female; D006801:Humans; D008297:Male; D011230:Precancerous Conditions / Q000517:prevention & control*; D011467:Prostate
chemical_list: D016588:Anticarcinogenic Agents